Description
Temazepam (CRM)
Temazepam (CRM) (Item No. ISO60182) is a certified reference material categorized as a benzodiazepine.1 Temazepam has sedative-hypnotic properties and misuse via intra-arterial injection has been associated with tissue damage and subsequent amputation.2,3 Temazepam is regulated as a Schedule IV compound in the United States. Temazepam (CRM) (Item No. ISO60182) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
WARNING This product is not for human or veterinary use.
Synonyms
Synonyms
- N-Methyloxazepam
- NSC 246303
- Ro 5-5345
- Ro 5-5354
- Wy 3917
Technical Information
Formal Name
7-chloro-1,3- dihydro-3- hydroxy-1- methyl-5- phenyl-1,4- benzodiazepin -2-one
CAS Number
846-50-4
Molecular Formula
C16H13ClN2O2
Formula Weight
300.7
Formulation(Request formulation change)
A 1 mg/ml solution in acetonitrile
SMILES
O=C1C(O)N=C(C2=CC=CC=C2)C(C=C(Cl)C=C3)=C3N1C
InChi Code
InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3
InChi Key
SEQDDYPDSLOBDC-UHFFFAOYSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form.
Shipping & Storage Information
Storage
-20°C
Shipping
Room Temperature in continental US; may vary elsewhere
Stability
≥ 5 years